ArticleCurrent oncology (Toronto, Ont.)2024

Monitoring the Response of Cyclin-Dependent Kinase 4/6 Inhibitors with Mean Corpuscular Volume.

Bediz Kurt İnci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.